Imatinib Mesylate for the Treatment of Steroid-Refractory Sclerotic-Type Cutaneous Chronic Graft-versus-Host Disease

Kristin Baird, Leora E. Comis, Galen O. Joe, Seth M. Steinberg, Fran T. Hakim, Jeremy J. Rose, Sandra A. Mitchell, Steven Z. Pavletic, William D. Figg, Lawrence Yao, Kathleen C. Flanders, Naoko Takebe, Stefanie Sarantopoulos, Susan Booher, Edward W. Cowen*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib Mesylate for the Treatment of Steroid-Refractory Sclerotic-Type Cutaneous Chronic Graft-versus-Host Disease'. Together they form a unique fingerprint.

Medicine & Life Sciences